OrthoSensor, a company that makes intelligent orthopedic implants and sensor-enabled surgical systems, recently declared arranging funding worth $21 million in Series B that came primarily from Ziegler Meditech Equity Partners.
The company’s orthopedic solutions will assist in surgeries and remote control and monitoring of implants, thus enhancing the quality of patient care undergoing orthopedic surgeries. Besides cutting costs on such surgeries and post operation monitoring of patients, the device will also minimize treatment cost of patients suffering from musculoskeletal disease.
OrthoSensor has used recent developments in the electronic and communications fields to produce a sensor enabled system that will offer surgeons comprehensive data on the location of the orthopedic implant and its condition after the surgery making the entire process of patient care accurate, time and cost-efficient.
The company has developed three product platforms, namely the OrthoSensor Surgical, OrthoSensor Implantables and OrthoSensor Analytics. The first product is a disposable, sensor-assisted product to offer intra-operative data to surgeons to guarantee exact balance and placement of implants. The device is a quick solution for particular orthopedic kinematics. When an implant is balanced with the soft tissue surrounding it, it enhances the time the implant can be left within the bone, thereby lowering the chances of repair surgeries and enabling the patient to move around faster.